4 recruiting, 2 completed, 1 withdrawn. 7 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Recruiting 4, Completed 2, Withdrawn 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Adolescent: new trials by email Literature Review of Adolescent trials Research Report on Adolescent
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients Romiplostim N01 - Solid Tumors, Hematological Tumor | Phase 2 | Recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 50 | 2025-12-25 | 2026-05-07 |
| Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Pediatric Solid Tumors Telpegfilgrastim Injection, filgrastim - Solid Tumors, Children | Phase 2 | Recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 132 | 2025-06-12 | 2026-05-07 |
| Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment Brentuximab Vedotin for Injection, response-adapted radiation, Doxorubicin - Classical Hodgkin Lymphoma, Child | Phase 2 / Phase 3 | Recruiting | Children's Cancer Group, China | 96 | 2024-09-25 | 2026-03-19 |
| A Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC) HTD1801, Ursodeoxycholic Acid - Primary Sclerosing Cholangitis, Cholangitis | Phase 2 | Withdrawn | HighTide Therapeutics (Hong Kong) Limited | 2021-03-01 | 2026-08-12 | |
| A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer Ramucirumab, Cyclophosphamide, Vinorelbine - Neoplasms, Child | Phase 2 | Recruiting | Eli Lilly and Company | 105 | 2020-01-22 | 2026-08-07 |
| Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds Phentermine, Immediate Release Topiramate, Placebo for Phentermine - Obesity, Morbid, Bariatric Surgery | Phase 2 | Completed | University of Colorado, Denver | 13 | 2020-01-15 | 2025-05-23 |
| An Open Study of Tipepidine Hibenzate in Adolescent Patients With Depression Tipepidine Hibenzate - Depression, Adolescent | Phase 2 | Completed | Chiba University | 10 | 2013-04-01 | 2014-05-23 |
Bile Duct Diseases (1) · Biliary Tract Diseases (1) · Cholangitis (1) · Cholangitis, Sclerosing (1) · Depression (1) · Digestive System Diseases (1) · Hematologic Neoplasms (1) · Neoplasms (1) · Obesity, Morbid (1)
Behavior (1) · Behavioral Symptoms (1) · Body Weight (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Obesity (1) · Overnutrition (1) · Overweight (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Cyclophosphamide (2) · Brentuximab Vedotin (1) · Dacarbazine (1) · Docetaxel (1) · Doxorubicin (1) · Etoposide (1) · Filgrastim (1) · Gemcitabine (1) · Injections (1) · Irinotecan (1) · Phentermine (1) · Prednisone (1) · Ramucirumab (1) · Temozolomide (1) · Topiramate (1)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences (2) · Chiba University (1) · Children's Cancer Group, China (1) · Eli Lilly and Company (1) · HighTide Therapeutics (Hong Kong) Limited (1) · University of Colorado, Denver (1)
China (3) · Japan (2) · United States (2) · Australia (1) · Belgium (1) · France (1) · Germany (1) · Italy (1) · Netherlands (1) · Spain (1) · United Kingdom (1)
Sidan Li (2) · Jaime M Moore, MD, MPH (1)
P30DK048520 (1)